Introduction {#S1}
============

PlexinA (PLXNA) is a family of cell-surface receptor proteins that guide developing axons to their targets within the central nervous system.^[@R1],[@R2]^ It is comprised of four genes, known as PlexinA1-A4.^[@R1],[@R3]^ Plexins form a receptor complex with neuropilins so as to bind semaphorins, thereby mediating the latter\'s chemorepulsive influence on axonal growth-cone development.^[@R2],[@R4]^ Plexins are expressed throughout the developing nervous system.^[@R5]^ However, an important part of their role in brain development is to guide developing cortical axons across the midline, thereby contributing to the formation of the corpus callosum,^[@R6]^ a large white matter bundle that links the two cerebral hemispheres. Molecular signaling through this pathway maintains an orderly position of axons as they cross the midline at the corpus callosum, thereby allowing the axons to reach their appropriate homotopic targets in the contralateral hemisphere.^[@R7]^

While most research on plexin has been conducted on *Drosophila, C. elegans* and rodents, recent studies of humans have linked common polymophisms in PLXNA4 with an increased risk of complex neurological disorders, including Alzheimer\'s disease,^[@R8]^ Parkinson\'s disease^[@R9]^ and autism.^[@R10]^ The link between risk alleles and abnormal brain development in these diseases may be found in atypical expression-levels or atypical structural isoforms of plexins. We present here the first study to examine the influence of variation in the *PLXNA* gene family on human white matter microstructure, with a focus on the developing corpus callosum.

Material and methods {#S2}
====================

We used diffusion tensor imaging (DTI), a magnetic-resonance-based technique that measures the diffusion of water,^[@R11]^ to assess white matter properties of the human corpus callosum during post-natal developmental. A major advantage of DTI is that it permits non-invasive *in vivo* measurements of white matter microstructure. Axon membranes are only semi-permeable to water, thereby creating a barrier to diffusion perpendicular to, but not parallel with, the main axis of white matter bundles. Fractional anisotropy (FA) is a DTI-derived measurement that quantifies the amount of diffusion parallel to, relative to perpendicular with, axon bundles.^[@R12]^ White matter bundles that take a straight path have high FA values, since the orientation of the resistance to diffusion is uniform throughout the bundle, whereas white matter bundles that take a tortuous path have lower FA values, since the direction of resistance to diffusion varies along the extent of the bundle.^[@R13]^

The data used in the present study were obtained from the Pediatric Imaging, Neurocognition and Genetics (PING) Study database (<http://ping.chd.ucsd.edu>). PING is a data resource comprised of highly standardized and carefully curated magnetic resonance imaging data, extensive genotyping data, and developmental and neuropsychological assessments for a large cohort of children three, collected across multiple sites. The PING database (version v0.4) was searched for single nucleotide polymorphisms (SNPs) within the *PLXNA1-4* genes. Genotype data for 1083 participants (ages 3--21 years, 521 female, 454 European, 110, African, 104 Asian, 64 South American, 12 Pacific Islands, 321 mixed ancestry, 18 other) were retrieved from the database along with FA **for** the corpus callosum for each participant. Data analysis was conducted in R v3.1.^[@R14]^ Additive models^[@R15]^ were used to test whether FA varied in the corpus callosum as a function of genotype and/or the interaction of genotype with age, using age, sex, genetic ancestry and data-collection site as covariates.

Results {#S3}
=======

The PING database contained 13 SNPs across the four *PLXNA* genes (see [Table 1](#T1){ref-type="table"}). For all plexin genotypes, corpus callosum FA increased throughout the course of development ([Figure 1](#F1){ref-type="fig"}), demonstrating a trend consistent with previous research on callosal development.^[@R16]^ Three of 13 SNPs in our dataset exhibited a main effect of genotype, indicating differences in corpus callosum FA that persisted across development. Ten SNPs exhibited interactions between genotype and age, indicating variation in the developmental trajectory of corpus callosum FA. Only three of the 13 SNPs failed to predict FA.

Discussion {#S4}
==========

Most of the PLXNA SNPs available in our database were introns and 3\' untranslated regions (3\'UTRs). Both types of regions regulate gene expression,^[@R17]^ suggesting that common polymorphisms within the *PLXNA* gene family may primarily affect the levels of gene expression. **Introns** can also regulate alternative splicing of exon sequences, resulting in different isoforms of a protein. Little is known about how plexin isoforms differ in function, and additional research is needed to elucidate their role in both typical and atypical brain development. However, SNPs can be statistically associated with nearby sequences through shared inheritance. This may explain the strong effects observed for a synonymous codon substitution for rs4679323. The SNPs that were analyzed in the present study may be statistically associated with nearby non-synonymous substitutions on exons that are not available in the PING database.

The present study demonstrates that natural variation in in the *PLXNA* family has a measurable influence on the microstructure of the largest white matter tract in the human brain. This is particularly manifested as an abnormal developmental trajectory of fractional anisotropy, suggesting that plexin may have a prominent role in postnatal regulation of white matter microstructure. The present study is an important step in understanding the relationship between these axon-guidance genes and complex neurological disorders in humans. Future research using similar *in vivo* methodologies should seek to link polymorphisms related to specific disorders with abnormal white matter microstructure in brain regions related to those disorders. Complementary research using molecular genetic methodologies will be vital in elucidating the cellular mechanisms that drive the influence of *PLXNA* variation on white matter maturation in the human brain.
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![Plexin-mediated developmental trajectory of corpus callosum microstructure\
A--J) Plots of corpus callosum FA as a function of age for the ten SNPs with significant main effects of genotype or interactions between genotype and age. Each plot includes the mean developmental trend (solid line) and one standard error above and below it (shaded area). The developmental trajectory for each genotype is plotted separately in each panel. In two cases (panels A and D), the developmental trajectory for homozygotes of the minor-frequency allele was based on too few observations, resulting in unreliable estimates of the developmental trend for those alleles. Plots for SNPs that showed a significant main effect of genotyped are marked with an asterisk. Lines showing a significant interaction between genotype and age are highlighted in bold. K) Midsagittal magnetic resonance image of the human brain with the corpus callosum indicated by black arrows.](nihms-644201-f0001){#F1}

###### Summary of SNPs and statistical tests

The table lists each PLXNA SNP in the PING database, the gene in which it is found, the SNPs location within the gene, and the number of participants who were homozygous for the major-frequency allele, heterozygous, or homozygous for the minor-frequency allele. The final columns list F-statistics and p-values for the main effect of genotype as well as the interaction between genotype and age. Degrees of freedom for additive models are reported in Supplementary Table 1. Estimates of power for additive models are reported in Supplementary Table 2. Tests of Hardy-Weinberg equilibrium are reported in Supplementary Table 3. Interactions reflect Wald-like statistics that test whether the developmental trend for each genotype differs from the mean developmental trend. Tests that are significant at the p\<0.05 level are highlighted in bold, and tests that survive Bonferonni correction for 52 comparisons are further marked with asterisks.

                                    Genotype counts              Interactions with Age                                                        
  -------- ------------ ----------- ----------------- ---------- ----------------------- ---------------- ----------------- ----------------- -----------------
  PLXNA1   rs1347003    Intron      433 (AA)          480 (GA)   170 (GG)                *F*=0.60         *F*=2.9           *F*=2.1           *F*=1.6
                                                                                         *p*=0.55         *p*=0.067         *p*=0.21          *p*=0.20
           rs9870165    Intron      858 (CC)          206 (AC)   19 (AA)                 *F*=0.95         *F*=0.58          *F*=0.60          ***F*=2.4**
                                                                                         *p*=0.39         *p*=0.51          *p*=0.50          ***p*=0.018**
           rs4679323    Cds-Synon   421 (AA)          486 (CA)   169 (CC)                ***F*=4.5**      ***F*=17.4**\*    ***F*=2.5**       *F*=3.4
                                                                                         ***p*=0.012**    ***p*=0.00032**   ***p*=0.017**     *p*=0.06
           rs4679325    Intron      908 (GG)          167 (AG)   8 (AA)                  *F*=2.3          *F*=1.33          *F*=1.2           *F*=0.14
                                                                                         *p*=0.11         *p*=0.24          *p*=0.29          *p*=0.74
           rs9851451    Intron      551 (AA)          423 (GA)   109 (GG)                *F*=1.8          ***F*=15.23**\*   ***F*=10.0**      *F*=0.13
                                                                                         *p*=0.17         ***p*=0.0008**    ***p*=0.006**     *p*=0.79
  PLXNA2   rs2767567    3\'UTR      927 (GG)          149 (AG)   7 (AA)                  ***F*=5.5**      ***F*=10.2**\*    *F*=1.1           *F*=0.96
                                                                                         ***p*=0.0044**   ***p*\<0.0001**   *p*=0.344         *p*=0.41
           rs591752     3\'UTR      735 (GG)          298 (AG)   50 (AA)                 *F*=0.22         ***F*=12.2**      *F*=1.3           *F*=4.2
                                                                                         *p*=0.80         ***p*=0.0026**    *F*=0.32          *p*=0.077
  PLXNA3   rs5945431    3\'UTR      826 (AA)          139 (GA)   118 (GG)                *F*=0.73         *F*=4.1           ***F*=15.1**\*    *F*=1.8
                                                                                         *p*=0.48         *p*=0.08          ***p*=0.00079**   *p*=0.24
  PLXNA4   rs11772555   3\'UTR      460 (AA)          454 (GA)   169 (GG)                *F*=1.4          ***F*=3.7**       *F*=1.3           ***F*=5.1**
                                                                                         *p*=0.26         ***p*=0.015**     *p*=0.31          ***p*=0.0038**
           rs2671101    Intron      916 (AA)          158 (CA)   8 (CC)                  *F*=0.02         *F*=2.1           *F*=0.85          *F*=0.4
                                                                                         *p*=0.98         *p*=0.13          *p*=0.42          *p*=0.64
           rs6977223    Intron      555 (AA)          432 (GA)   96 (GG)                 *F*=0.99         *F*=0.87          *F*=1.4           ***F*=4.3**
                                                                                         *p*=0.37         *p*=0.41          *p*=0.21          ***p*=0.024**
           rs281875     Intron      772 (GG)          276 (AG)   35 (AA)                 *F*=0.36         *F*=0.15          *F*=0.5           ***F*=15.8**\*
                                                                                         *p*=0.70         *p*=0.74          *p*=0.55          ***p*=0.00059**
           rs10231824   Intron      419 (GG)          491 (AG)   173 (AA)                ***F*=4.3**      ***F*=8.2**       *F*=2.0           ***F*=15.2**\*
                                                                                         ***p*=0.015**    ***p*=0.013**     *p*= 0.22         ***p*=0.00075**

[^1]: Data used in the preparation of this article were obtained from the Pediatric Imaging, Neurocognition and Genetics Study (PING) database (<http://ping.chd.ucsd,edu>). As such, the investigators within PING contributed to the design and implementation of PING and/or provided data but did not participate in analysis or writing of this report. A complete listing of PING investigators can be found at [https://ping-dataportal.ucsd.edu/sharing/Authors10222012.pdf](http://https://ping-dataportal.ucsd.edu/sharing/Authors10222012.pdf).
